These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11313329)

  • 1. Methotrexate for the maintenance of remission in Crohn's disease.
    Yang YX; Lichtenstein GR
    Gastroenterology; 2001 May; 120(6):1553-5. PubMed ID: 11313329
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
    Feagan BG; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Koval J; Wong CJ; Hopkins M; Hanauer SB; McDonald JW
    N Engl J Med; 2000 Jun; 342(22):1627-32. PubMed ID: 10833208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.
    Feagan BG; Rochon J; Fedorak RN; Irvine EJ; Wild G; Sutherland L; Steinhart AH; Greenberg GR; Gillies R; Hopkins M
    N Engl J Med; 1995 Feb; 332(5):292-7. PubMed ID: 7816064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
    Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate for maintenance of remission in Crohn's disease.
    Patel V; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006884. PubMed ID: 19821390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for Crohn's disease.
    Korelitz BI; Present DH
    N Engl J Med; 1995 Aug; 333(9):600-1. PubMed ID: 7623920
    [No Abstract]   [Full Text] [Related]  

  • 7. [A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators].
    Martreau P
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1243-4. PubMed ID: 11277090
    [No Abstract]   [Full Text] [Related]  

  • 8. [Sustaining remission in Crohn disease with methotrexate--a placebo controlled study].
    Roznowski AB; Dignass A
    Z Gastroenterol; 2001 Mar; 39(3):265-7. PubMed ID: 11324144
    [No Abstract]   [Full Text] [Related]  

  • 9. Methotrexate treatment for Crohn's disease.
    Feagan BG
    Inflamm Bowel Dis; 1998 May; 4(2):120-1. PubMed ID: 9687221
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate and maintenance of remission in Crohn's disease.
    Fishman M
    Can J Gastroenterol; 2001 Jul; 15(7):428. PubMed ID: 11493943
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
    Schmidt C; Wittig BM; Moser C; Zeitz M; Stallmach A
    Aliment Pharmacol Ther; 2006 Jul; 24(2):343-50. PubMed ID: 16842461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy].
    Choi JR; Yun GW; Park YM; Kim JH; Youn YH; Park HJ; Park JJ
    Korean J Gastroenterol; 2015 Oct; 66(4):231-6. PubMed ID: 26493510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and tolerability of methotrexate for treating patients with Crohn's disease.
    Chande N; Abdelgadir I; Gregor J
    J Clin Gastroenterol; 2011 Aug; 45(7):599-601. PubMed ID: 21224737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there any remaining role for methotrexate for Crohn's disease?
    Korelitz BI
    Dig Liver Dis; 2003 Sep; 35(9):610-1. PubMed ID: 14563181
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate for refractory Crohn's disease: preliminary answers to definitive questions.
    Kozarek RA
    Mayo Clin Proc; 1996 Jan; 71(1):104-5. PubMed ID: 8538222
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C; Beau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):153-7. PubMed ID: 18343615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methotrexate in therapy of chronic inflammatory bowel diseases].
    Schröder O; Stein J
    Z Gastroenterol; 1996 Jul; 34(7):457-8. PubMed ID: 8928541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.